Literature DB >> 31041652

Normal D-dimer levels in cancer patients with radiologic evidence of pulmonary embolism.

Aiham Qdaisat1, Carol C Wu2, Sai-Ching Jim Yeung3,4.   

Abstract

Accurate and expeditious diagnosis and treatment of pulmonary embolism in cancer patients improves patient outcomes. D-dimer is often used to rule out pulmonary embolism. However, this test is less accurate in cancer patients, and it is unclear whether cancer patients with normal D-dimer levels can present with pulmonary embolism. All consecutive patients who presented to The University of Texas MD Anderson Cancer Center in Houston, Texas, USA, between May 2009 and November 2015 who underwent computed tomography pulmonary angiography and plasma D-dimer level measurement were retrospectively reviewed. Patients with suspected pulmonary embolism and normal D-dimer levels were identified. Among the 8023 cancer patients identified, 1156 (14%) had pulmonary embolism. Only 35 patients with pulmonary embolism (3%) had normal plasma D-dimer levels. Twenty-six of these patients had acute pulmonary embolism and the other nine had subacute or chronic pulmonary embolism. Thirteen of the 26 acute cases were in patients with hematological cancer. Most patients (23/35, 66%) had subsegmental or segmental pulmonary embolism. Only one patient had pulmonary embolism in the main pulmonary arteries. Although it is uncommon (3%), cancer patients with radiologic evidence of pulmonary embolism can present with normal D-dimer levels. Recognizing the possibility of this uncommon occurrence is critical in the decision process for ordering diagnostic tests for evaluation of suspected pulmonary embolism.

Entities:  

Keywords:  Cancer; D-dimer; Normal; Pulmonary embolism; Thrombosis; Venous thromboembolism

Mesh:

Substances:

Year:  2019        PMID: 31041652      PMCID: PMC6556415          DOI: 10.1007/s11239-019-01863-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  16 in total

1.  Usefulness of a semiquantitative D-dimer test for the exclusion of deep venous thrombosis in outpatients.

Authors:  Roger E G Schutgens; Earl U Esseboom; Fred J L M Haas; H Karel Nieuwenhuis; Douwe H Biesma
Journal:  Am J Med       Date:  2002-06-01       Impact factor: 4.965

2.  Clinical utility of a rapid whole-blood D-dimer assay in patients with cancer who present with suspected acute deep venous thrombosis.

Authors:  A Y Lee; J A Julian; M N Levine; J I Weitz; C Kearon; P S Wells; J S Ginsberg
Journal:  Ann Intern Med       Date:  1999-09-21       Impact factor: 25.391

3.  A rapid D-dimer assay in patients presenting at the emergency room with suspected acute venous thrombosis: accuracy and relation to clinical variables.

Authors:  S Siragusa; V Terulla; S Pirrelli; C Porta; F Falaschi; R Anastasio; R Guarnone; M Scarabelli; A Odero; M A Bressan
Journal:  Haematologica       Date:  2001-08       Impact factor: 9.941

4.  Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism.

Authors:  Marc Righini; Grégoire Le Gal; Sylvain De Lucia; Pierre-Marie Roy; Guy Meyer; Drahomir Aujesky; Henri Bounameaux; Arnaud Perrier
Journal:  Thromb Haemost       Date:  2006-04       Impact factor: 5.249

Review 5.  Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy.

Authors:  F Couturaud; C Kearon; S M Bates; J S Ginsberg
Journal:  Blood Coagul Fibrinolysis       Date:  2002-04       Impact factor: 1.276

6.  Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.

Authors:  A A Khorana; C W Francis; E Culakova; N M Kuderer; G H Lyman
Journal:  J Thromb Haemost       Date:  2007-03       Impact factor: 5.824

7.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.

Authors:  Alok A Khorana; Charles W Francis; Eva Culakova; Nicole M Kuderer; Gary H Lyman
Journal:  Cancer       Date:  2007-11-15       Impact factor: 6.860

Review 8.  D-Dimer for venous thromboembolism diagnosis: 20 years later.

Authors:  M Righini; A Perrier; P De Moerloose; H Bounameaux
Journal:  J Thromb Haemost       Date:  2008-07-01       Impact factor: 5.824

Review 9.  Venous thromboembolism and cancer: risks and outcomes.

Authors:  Agnes Y Y Lee; Mark N Levine
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

10.  Prediction of pulmonary embolism in the emergency department: the revised Geneva score.

Authors:  Grégoire Le Gal; Marc Righini; Pierre-Marie Roy; Olivier Sanchez; Drahomir Aujesky; Henri Bounameaux; Arnaud Perrier
Journal:  Ann Intern Med       Date:  2006-02-07       Impact factor: 25.391

View more
  2 in total

1.  Clinical characteristics, management, and outcome of incidental pulmonary embolism in cancer patients.

Authors:  Aiham Qdaisat; Mona Kamal; Aisha Al-Breiki; Biman Goswami; Carol C Wu; Shouhao Zhou; Terry W Rice; Kumar Alagappan; Sai-Ching Jim Yeung
Journal:  Blood Adv       Date:  2020-04-28

2.  Risk Assessment of Death of Tumor-Related PTE by CAR Combined with DD Detection.

Authors:  Xinran Li; Jiamin Zheng; Ye Lu; Xiangtao Pan
Journal:  Vasc Health Risk Manag       Date:  2022-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.